ExplainerThis week in Covid vaccines: A collection of the FT’s essential readingRollouts are gathering pace but rancour over approvals and strategy dominated in Europe© FT montage; Getty Images; BloombergIsrael provides first signs of mass vaccination driving down virus casesData from country with fastest rollout offers clear indication that jabs are slowing pandemicEmmanuel Macron under pressure as Covid vaccination rollout faltersFrench president’s handling of crisis raises questions about his chances in 2022 presidential pollHow to take on Covid conspiracy theories As vaccines are rolled out around the globe, we are more vulnerable than ever to disinformationVaccine milestone as global Covid jabs pass number of confirmed casesFT tracker shows rapid growth in doses administered around world — but warnings come of long road aheadSwiss medical regulator rejects Oxford/AstraZeneca Covid vaccineSwissMedic says available trial data ‘not yet sufficient’ to authorise its useFrench panel advises against giving Oxford/AstraZeneca jab to over-65sMore European countries raise concerns about Covid vaccine’s efficacy in older peopleMore from this SeriesRussia’s Sputnik vaccine shows 91.6% efficacy in clinical trialsLancet peer review confirms performance of country’s flagship two-shot jabBalkan nations turn to China and Russia for jabsShut out by Europe, aspiring EU members are looking east for coronavirus vaccinationsUrsula von der Leyen feels the heat over vaccine exports hiccupCommission president’s move to block jab exports angered neighbours and forced U-turn
